In focus · trending topic

Altomari

23 stories · following the connections

Agile Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results

By Nasdaq OMXMar 12, 2018, 8:15 PM UTC

Agile Therapeutics to Host First Analyst Day on October 10, 2017

By Nasdaq OMXOct 2, 2017, 11:30 AM UTC

Agile Therapeutics to Present Additional Phase 3 Data at the North American Forum on Family Planning Annual Meeting

By Nasdaq OMXSep 28, 2017, 11:45 AM UTC

Agile Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference

By Nasdaq OMXSep 14, 2017, 11:45 AM UTC

Agile Therapeutics to Present Additional Phase 3 Data at the 73rd Annual Congress of the American Society for Reproductive Medicine

By Nasdaq OMXSep 7, 2017, 11:50 AM UTC

Agile Therapeutics Reports Second Quarter 2017 Financial Results

By Nasdaq OMXJul 28, 2017, 11:30 AM UTC

Agile Therapeutics Announces FDA Acceptance of the NDA Resubmission of Twirla®

By Nasdaq OMXJul 27, 2017, 8:12 PM UTC

Agile Therapeutics to Present Additional Phase 3 Data at the 2017 Annual Clinical and Scientific Meeting of the American Congress of Obstetricians and Gynecologists

By Nasdaq OMXMay 3, 2017, 8:15 PM UTC